残る証拠のギャップを埋める:低密度リポプロテイン ≥190 mg/dLのためのスタチンの治療を支援するランダム化制御試験データ
Karol E Watson1,2, Gregg C Fonarow3,4
1Division of Cardiology, David Geffen School of Medicine at University of California, Los Angeles (UCLA) (K.E.W., G.C.F.). kwatson@mednet.ucla.edu.
No abstract available in PubMed .
さらに関連する動画
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
08:45LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
関連する概念動画
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipids: Dietary Sources and Requirements
